openPR Logo
Press release

Vitreous Tamponades Market to be Valued at US$77.5 bn by 2020 Rising from US$64.5 bn in 2014

07-10-2017 08:00 AM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Vitreous Tamponades Market to be Valued at US$77.5 bn by 2020

Vitreous humor of the human eye is a vital component that acts as nutrition and refractive medium. The vitreous humor is initially a highly viscous gel like substance made up of collagen fibers and water. In case of trauma or upon aging, the vitreous humor disintegrates and in the process ends up tearing or detachment of highly fragile retina. Thus, these retinal detachment and vitreoretinal disorders often require an ophthalmic surgical procedure known as vitrectomy. Vitrectomy procedure involves surgical removal of the vitreous humor that is replaced with synthetic substitute known as vitreous tamponade. These vitreous tamponades act as a retinal reattachment medium thereby aiding the healing process.

Read the Comprehensive Overview of Vitreous Tamponades Market: http://www.transparencymarketresearch.com/vitreous-tamponades-market.html

The global vitreous tamponade market is studied based on the types of tamponades and geography. Based on tamponade types, the market have been further segmented into two major sub segments namely, gaseous tamponades and liquid tamponades. Between product segments, liquid tamponade segment accounted for the largest share (in terms of revenue) of the market, in 2013. Liquid tamponades have widespread usage across Asia Pacific, Europe and RoW due to their effectiveness in treating high degree of retinal tear. Gaseous tamponades on the other hand are expected to grow at a faster rate compared to liquid tamponades, owing to its lower costs and ease of use. The liquid tamponades segment has been further categorized into silicone oil and perfluorocarbons. Of these, silicone oil segment captured majority of the market share in 2013. The perfluorocarbons have limited use and are used as an intra operative tool during the treatment of giant retinal breaks.

In terms of regional distribution, North America currently accounts for the largest share of the global vitreous tamponades market followed by Europe. Furthermore, North America with a market share of more than 30% is expected to dominate the industry during the forecast period. The dominance of this region was majorly due to high awareness about vitreoretinal disorders, availability of premium priced tamponades and soaring prevalence of age related macular degeneration and retinal detachment. On the other hand, Asia Pacific is expected to witnesses highest growth rate (CAGR) in the vitreous tamponade market during the forecast period. The presence of a large diabetic population in countries such as China, India and South East Asia and increasing number of tamponade manufacturers are some of the primary reasons supporting the growth of this region.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4233

The global vitreous tamponade market is highly fragmented and region specific. Alcon, Inc., Valeant Pharmaceuticals International, Inc. (parent of Bausch + Lomb), Carl Zeiss Meditec AG, Dutch Ophthalmic Research Center B.V., Fluoron GmbH, Croma Pharma AG, and AL.CHI.MI.A Srl are few players operating in this market.

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vitreous Tamponades Market to be Valued at US$77.5 bn by 2020 Rising from US$64.5 bn in 2014 here

News-ID: 615492 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Vitreous

Vitreous Tamponades Market by Type, End Users, and Region
Vitreous substitutes are used as intraoperative and postoperative tool for surgical treatment of vitreoretinal disease. They are used as temporary fillers, permanent fillers or used as surgical tool during short intraocular surgery. According to the data published by National Center for Biotechnology Information (NCBI) in January 2014, retinal detachment is the most common vision-threatening retinal condition, with an incidence of 1 in 10,000 individual annually, which corresponds to around 8,000 new
02-04-2018 | Health & Medicine
TMR
Vitreous Tamponades Market Forecast to 2023
Transparency Market Research (TMR) in a new market study reports that the global vitreous tamponades market is highly fragmented with the presence of small and medium sized players. A distinct feature of the market is that each region is dominated by a select number of players. For instance, the vitreous tamponades market in North America is dominated by Novartis AG and Valeant Pharmaceuticals that hold more than 50% of market share. Likewise, the
Vitreous Tamponades Market Analysis and Key Trends 2025
Transparency Market Research (TMR) in a new market study reports that the global vitreous tamponades market is highly fragmented with the presence of small and medium sized players. A distinct feature of the market is that each region is dominated by a select number of players. For instance, the vitreous tamponades market in North America is dominated by Novartis AG and Valeant Pharmaceuticals that hold more than 50% of market
10-11-2017 | Health & Medicine
TMR
Vitreous Tamponades Market Report 2014
Transparency Market Research (TMR) has announced the addition of a new market study based on the vitreous tamponades market. The report analyzes the drivers and restraints of the vitreous tamponades market and the impact of these on the demand for vitreous tamponades during the forecast period from 2014 to 2020. The report studies the attractiveness of the vitreous tamponades market for investment on the basis of factors such as growth
Vitreous Tamponades Market to Discern Magnified Growth During 2020
The competitive landscape of the global vitreous tamponades market is highly fragmented due to the presence of numerous local and global players, states Transparency Market Research (TMR). Some of the top players operating in the global vitreous tamponades market are Carl Zeiss Meditec AG, Alcon Inc., Fluron GmbH, Valeant Pharmaceuticals International Inc., and Dutch Ophthalmic Research Center B.V. “Expansion of distribution networks and distributor subsidiaries is the strategy top companies
Vitreous Tamponades Market Analysis & Trends 2020
The competitive landscape of the global vitreous tamponades market is highly fragmented due to the presence of numerous local and global players, states Transparency Market Research (TMR). Some of the top players operating in the global vitreous tamponades market are Carl Zeiss Meditec AG, Alcon Inc., Fluron GmbH, Valeant Pharmaceuticals International Inc., and Dutch Ophthalmic Research Center B.V. “Expansion of distribution networks and distributor subsidiaries is the strategy top companies